Brind.

Brainstorm (Q30255242) faced non-compliance with minimum shareholder equity requirements on July 18, 2025, and secured approval for a continuous trading platform.

1 report, 1 independent Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Brainstorm (Q30255242) faced non-compliance with minimum shareholder equity requirements on July 18, 2025, and secured approval for a continuous trading platform.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireBrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB NEW YORK, July 17, 2025 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that it has received a delisti